About Index Trending news
Lists
Pricing
SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

23 Apr 2017

SteadyMed raises $30m for Trevyent commercial launch

Drug Delivery Business
+1
30 Jul 2016
$32,000,000
Post-IPO equity
OrbiMed, Deerfield Capital Management, Federated Investors
03 Feb 2015
$122
Venture capital
08 Apr 2013
$3,000,000
Debt financing
17 Sep 2012
$10,400,000
Venture capital
28 Jan 2009
$2,000,000
Venture capital (Series A)